Xeris details Phase 3 plan for weekly hypothyroidism therapy XP-8121Sep 9PeopleXeris Biopharma Holdings, Inc.
Xeris reports second-quarter 2026 results, tightens full-year revenue guidanceAug 6Quarterly updatelevoketoconazoleXeris Biopharma Holdings, Inc.
Sign inSign in